|
Positively Positive - Living with HIV/AIDS:
HIV/AIDS News Archive - May 2023
Addressing the Oral Health Needs of People Living with HIV/AIDS
May 31, 2023 - by Helene Ragovin - In a recent addition to dental school curriculum, students gain experience and insight while providing this much-needed care
People living with HIV/AIDS often experience an assortment of oral health ailments. In fact, the mouth can be the first place that symptoms from HIV infection appear.
So it’s particularly important for HIV-positive people to keep on top of their dental checkups, and for dentists to be aware of the complications they can face. At Tufts University School of Dental Medicine (TUSDM), the curriculum now incorporates training at a Boston day program dedicated to improving quality of life for those living with HIV, as part of a unit focusing on care for vulnerable populations.
Frontier Science and QualityMetric Collaborate on Worldwide Treatment Study in Youth Living with HIV
BOSTON, May 31, 2023 /PRNewswire/ - Frontier Science, the Data Management Center for the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network, and QualityMetric, a leading global provider of patient-reported outcome (PRO) and clinical outcome assessment (COA) solutions, announced their collaboration on IMPAACT 2036/CRAYON: The Cabotegravir and Rilpivirine Long-Acting Injections in YOung ChildreN study. This critical study will assess the safety, tolerability, acceptability, and pharmacokinetics of these newly developed long-acting medications in children living with HIV-1. The study will enroll up to ninety children between the ages of 2 and 12 worldwide over the next three years.
HRC’S TRANSFORMATIONAL WORK ADVANCING HIV & HEALTH EQUITY PROGRAMMING FOR BLACK AND LATINÉ LGBTQ+ COMMUNITIES TO EXPAND OVER NEXT THREE YEARS WITH SUPPORT FROM GILEAD SCIENCES
Washington, D.C. - May 31, 2023 - by Jarred Keller - HRC AND GILEAD SCIENCES TO DEVELOP PROGRAMMING TO END THE HIV EPIDEMIC BY 2030 THROUGH $5M GRANT FUNDING
The Human Rights Campaign (HRC), the nation’s largest lesbian, gay, bisexual, transgender and queer (LGBTQ+) civil rights organization, is proud to announce the expansion of its work -- supported by a three-year, $5 million grant from Gilead Sciences, Inc. -- to eradicate the stigma surrounding HIV in Black and Latiné communities and end the HIV epidemic by 2030.
Lambda Legal to Pentagon: It’s Time to Let People Living with HIV Join the Military
(Washington, DC, May 31, 2023) - Today, Lambda Legal asked a U.S. District Court to strike down the last remaining ban preventing people living with HIV from joining any branch of the U.S. Armed Services. Together with co-counsel Winston & Strawn LLP, Perkowski Legal, PC, and Scott A. Schoettes, Esq., Lambda Legal filed a motion for summary judgment in the U.S. District Court for the Eastern District of Virginia.
The report is comprised of quantitative data and personal stories gathered from more than 2,500 community members who participated in our survey about their experiences with the criminal legal system including police and other law enforcement, courts, prisons, jails, schools, and other government agencies.
Celebrating HIV Long-Term Survivors Awareness Day 2023
May 30, 2023 - by Hank Trout, MA - On June 5, we honor and celebrate the strength and resilience of those of us who have survived the HIV and AIDS epidemic. We deserve to thrive; we deserve to celebrate. Join us, won’t you!
On June 5, 1981, the U.S. Centers for Disease Control (CDC) published an article in Morbidity and Mortality Weekly Report (MMWR) entitled “Pneumocystis Pneumonia – Los Angeles,” detailing cases of a rare lung infection, Pneumocystis carinii pneumonia (PCP), found in five young, otherwise healthy gay men in Los Angeles. On the same day that the MMWR published this report, New York dermatologist Dr. Alvin Friedman-Kien reported to the CDC a cluster of cases of a rare and unusually aggressive cancer, Kaposi’s sarcoma (KS), among young gay men in New York and California. Thus, June 5, 1981, is acknowledged as the date of the very first reports of the disease that would become known as Acquired Immunodeficiency Disease — AIDS.
Read more...
4,000-year-old plague DNA found – the oldest cases to date in Britain
30-May-2023 - Researchers at the Francis Crick Institute have identified three 4,000-year-old British cases of Yersinia pestis, the bacteria causing the plague – the oldest evidence of the plague in Britain to date, reported in a paper published today in Nature Communications.
Working with the University of Oxford, the Levens Local History Group and the Wells and Mendip Museum, the team identified two cases of Yersinia pestis in human remains found in a mass burial in Charterhouse Warren in Somerset and one in a ring cairn monument in Levens in Cumbria.
Researchers Use ‘Natural’ System to Identify Proteins Most Useful for Developing an Effective HIV Vaccine
05/30/2023 - Johns Hopkins Medicine-led team shows technique can find protein fragments that best stimulate the immune system to recognize and attack the virus
Since it was identified in 1984 as the cause of Acquired Immune Deficiency Syndrome (AIDS), the human immunodeficiency virus (HIV) has infected more than 80 million people and been responsible for some 40 million deaths worldwide, according to the World Health Organization (WHO). Currently, the WHO reports more than 38 million people globally live with the retrovirus, and each year, another 1 million new cases are diagnosed. While antiretroviral therapy helps keep HIV in check, patients must stay on their medication to prevent the development of AIDS.
Addressing Stigma and Discrimination Against People Living With HIV
May 30, 2022 - The relationship between HIV and stigma is long-standing and intertwined, with far-reaching implications for those living with the disease. In the early days of the HIV epidemic, HIV/AIDS was commonly called as “gay cancer,” causing LGBTQIA+ people and those living with HIV to experience profound shame and discrimination. The derogatory term “4H club” also emerged, further stigmatizing individuals at risk, including those who injected heroin, those with hemophilia and Haitian people. Another early name for AIDS was “gay-related immune deficiency,” or GRID. It was not until 1984 that HIV was characterized as the cause for AIDS and AIDS-related illnesses.
Long-Term HIV Treatment Research Data Published in Leading Clinical Journal
May 30, 2023 - Five-year cumulative data from two Phase 3 studies (Study 1489 and Study 1490) of Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg tablets, B/F/TAF) has been published in eClinicalMedicine, a Lancet journal publication. The Week 240 results further reinforce Biktarvy’s role as a guidelines recommended treatment option for a broad range of people with HIV and demonstrated the sustained efficacy and durable viral suppression of the single-tablet regimen. The data support the long-term use of Biktarvy, with no significant changes to metabolic, bone, and renal health markers through five years.
Joint Statement by the Leaders of the Global Fund, UNAIDS and PEPFAR on Uganda’s Anti-Homosexuality Act 2023
GENEVA | WASHINGTON, D.C., 29 May 2023 - The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), the Joint United Nations Programme on HIV/AIDS (UNAIDS), and the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) are deeply concerned about the harmful impact of the Ugandan Anti-Homosexuality Act 2023 on the health of its citizens and its impact on the AIDS response that has been so successful up to now.
3 tick-borne diseases, mpox added to list of notifiable diseases, illnesses in N.S.
May 28, 2023 - by Michael Gorman - List is updated based on observations by labs, health-care providers
Nova Scotia is adding four diseases — three related to tick bites — to the list of illnesses and conditions that health-care professionals and lab staff must report to Public Health upon observation.
Read more...
HIV stigma index researchers look for Manitobans with positive diagnoses to share experience
May 28, 2023 - Written by Patrick Kelleher - Researchers hope to speak with at least 75 people living with HIV in Manitoba
Manitoba researchers looking for people to take part in a national HIV Stigma Index project are only about halfway to their goal of hearing from at least 75 people living with a positive diagnosis.
The international peer-driven research project helps understand the stigma associated with HIV and supports those living with a diagnosis.
Read more...
I was there when the AIDS crisis hit – this is what the history books get wrong, says Paul Burston
May 28, 2023 - Paul Burston was a young gay man finding his way when the AIDS epidemic hit. As he releases his memoir, he tells PinkNews how activism saved him – and how history is being rewritten.
Early adulthood should be a time for exploration – but for an entire generation of queer people, those formative years were marred by the arrival of a mystery virus that was killing perfectly healthy people.
Read more...
Taking the Next Step Towards Ending HIV – Op-ed by U.S. Ambassador to Ghana Virginia Palmer
27 May, 2023 - By U.S. Embassy in Ghana - Twenty years ago on May 27, 2003, President George W. Bush signed the President’s Emergency Plan for AIDS Relief (PEPFAR) into law. In the 20 years since, the PEPFAR program has partnered with host governments to save 25 million lives in 50 countries across the globe, including Ghana. Gifty, a 52-year-old woman in the Ahafo region, is one of those lives. She started getting sick and couldn’t understand why. She was ostracized by her family and community and even called a witch. Her business suffered. Her brother tried to help and get medicine – without even telling her what it was or what she had. The medicine ran out and her condition worsened. She became almost blind and was deathly ill. Then, a PEPFAR- funded HIV case manager came to her house. After counseling, Gifty was tested for HIV and immediately put on treatment. Today, her condition has turned around. She was able to restart her trading activities, selling at the local market without attracting discrimination or stigma.
Living healthy lives with HIV for decades thanks to ARVs
Mbarali - May 27, 2023 - By Alawi Masare - When he tested HIV-positive in 1993, Douglas Kisunga thought it was a death sentence. It got worse when doctors told him that there was neither medicine nor a vaccine against the viral disease.
Thirty years later, the 70-year-old man is still going strong, and the virus in his body is neither detected nor infectious thanks to proper use of the antiretroviral drugs (ARVs), which are now delivered for free in Tanzania.
Read more...
ECDC Director vacancy now open
May 26 2023 - The vacancy notice for the next Director of the European Centre for Disease Prevention and Control (ECDC) has now been published in the EU Official Journal, marking the beginning of the recruitment process for the most senior role in the Centre.
The next ECDC Director will have a key role in achieving the Centre’s vision to improve lives in Europe and globally, by applying scientific excellence and empowering EU Member States, the European Commission, and other partners to drive public health policy and practice.
Dennis Research Group Releases New White Paper On Molecular HIV Epidemiology
May 25, 2023 - The Dennis Research Group in the School of Medicine has released a new white paper titled, “Revitalizing Community Engagement in the Public Health Use of Molecular HIV Epidemiology.”
The paper is a product of the UNC Ethics of HIV Molecular Surveillance Project, funded through an administrative supplement to the NIAID-funded R01 Phylodynamics Response, Monitoring, & Prevention of Transmission (HIV PROMPT; PI Ann Dennis, R01Al135970).
OHSU research offers clues for potential widespread HIV cure in people
Portland, Oregon - May 25, 2023 - By Franny White - New study reveals first details on how stem cell transplantation can kill virus that causes AIDS
New research from Oregon Health & Science University is helping explain why at least five people have become HIV-free after receiving a stem cell transplant. The study’s insights may bring scientists closer to developing what they hope will become a widespread cure for the virus that causes AIDS, which has infected about 38 million people worldwide.
How peer support workers are leading the way in preventing the spread of HIV in northern Ontario
May 25, 2023 - Sarah Law - Federal government announces $2.6 million for peer support program at Elevate NWO office
Much of the published dialogue and media representation surrounding the epidemic primarily center the harrowing mortality statistics or the subsequent scientific advancement. While these are irrefutable parts of the crisis, it often leaves out the human aspect, erasing the very real impact on relationships, families, and communities.
Read more...
Timelier than ever, Keith Haring’s first L.A. museum show shines a neon-bright light on his art and activism
May 25, 2023 - BY DEBORAH VANKIN - Keith Haring climbed atop scaffolding inside a classroom building at Pasadena’s ArtCenter College of Design and began to quietly but determinedly paint. It was late November 1989, and the New York artist and activist, who was HIV positive at the time, had been invited to the college to speak to students and paint a mural on the occasion of the second World AIDS Day.
Read more...
$3.4M grant to tackle ‘biggest challenge’ to HIV cure
May 24, 2023 - By Krishna Ramanujan - Cornell researchers will use a five-year, $3.4 million grant from the National Institutes of Health to investigate whether chemical inhibitors of epigenetic regulation – including many FDA-approved drugs – could be re-purposed to treat HIV-1 infections that are persistent in tissues and represent the biggest challenge for a cure.
Researchers identify strong T-cell response in first-in-human nanoparticle HIV vaccine
SEATTLE – MAY 24, 2023 - Study result moves scientists closer to developing elusive HIV vaccine
Researchers from Fred Hutchinson Cancer Center in Seattle, Scripps Research in La Jolla, California, IAVI and other collaborating institutions have characterized robust T-cell responses in volunteers participating in the IAVI G001 Phase 1 clinical trial to test the safety and immune response of a self-assembling nanoparticle HIV vaccine.
Their work, published in Science Translational Medicine, signals a major step toward development of a vaccine approach to end the HIV/AIDS epidemic worldwide. The antigen used in this study was jointly developed by IAVI and Scripps Research and has been shown in previous analyses to stimulate VRC01-class B cells, an immune response considered promising enough for boosting in further studies.
Readily Available Dietary Supplement Reverses HIV-Related Organ Damage in Preclinical Trials
May 24, 2023 - MitoQ, a publicly accessible dietary supplement that acts as a mitochondrial antioxidant, was discovered through a mouse study to counteract the harmful impacts that HIV and antiretroviral therapy (ART) inflict on the mitochondria within the brain, heart, aorta, lungs, kidney, and liver.
Government of Canada supports community-based projects addressing HIV, Hepatitis C, and other sexually transmitted and blood-borne infections
May 24, 2023 - Today, during a visit to Elevate NWO, the Honourable Jean-Yves Duclos, announced $30.5 million through the HIV and Hepatitis C Community Action Fund (CAF) and the Harm Reduction Fund (HRF) for 37 projects across Ontario. The funding will support the work of community-based organizations addressing HIV, hepatitis C and other sexually transmitted and blood-borne infections (STBBI). STBBI are preventable, treatable and in many cases curable. However, these infections remain a significant public health concern in Canada and around the world.
UNAIDS alerts countries to an unprecedented opportunity to stop new HIV infections, end AIDS and prepare for future pandemics
GENEVA, 24 May 2023 - UNAIDS urges countries to take full advantage of new opportunities to step up funding, expand new and proven HIV prevention technologies and remove barriers to HIV services. Taking action today will boost progress to end AIDS and respond to current pandemics and pandemics of the future.
U.S. Ranks Near Bottom in Preventing New HIV Cases
May 23, 2023 – by Ged Kenslea - Twelve percent decrease pales in comparison to success rates of most other industrialized nations in getting people living with HIV on treatment and virally suppressed
AIDS Healthcare Foundation (AHF) and the Pan American Health Organization (PAHO) met in Washington D.C. earlier this week, where the organizations entered into an official partnership to fight HIV/AIDS, other sexually transmitted infections, and other conditions, including tuberculosis, hepatitis viruses, and mpox.
U.S. progress in HIV fight continues to trail many other rich nations
May 23, 2023 - By Benjamin Ryan - New transmissions declined by 12% nationally between 2017 and 2021, and racial disparities have abated only slightly during this time period, according to a new CDC report.
New HIV infections continue to ebb only modestly in the United States, while many other wealthy Western nations have posted steep reductions, thanks to more successful efforts overseas to promptly diagnose and treat the virus and promote the HIV prevention pill, PrEP.
Read more...
Age and CD4 count have the greatest influence on life expectancy in the modern HIV treatment era
23 May 2023 - Rosalie Hayes - A study published in this month’s Lancet HIV claims to have produced one of the most detailed analyses of life expectancy among people living with HIV in high-income countries in the modern treatment era. It found that for people on antiretroviral therapy (ART) and with high CD4 cell counts, life expectancy was only a few years lower than the general population, regardless of when they had started treatment.
Read more...
URBAN GARDEN PROJECT SEEKS TO REDUCE FOOD INSECURITY AND IMPROVE OUTCOMES FOR PEOPLE WITH HIV
May 23, 2023 - UMass Amherst researcher awarded $3.4 million grant for intervention in Dominican Republic
A University of Massachusetts Amherst public health scientist has received a five-year, $3.4 million grant from the National Institute of Mental Health to lead an urban gardening and peer nutritional counseling program aimed at improving the health of HIV-positive people with food insecurity in the Dominican Republic.
Aphios Awarded an NIH Grant to Develop a Double Encapsulated mRNA Vaccine For COVID-19 and Other Diseases.
Woburn, Mass. – May 23, 2023 - Aphios announced today that it was awarded an NIH grant to develop a double encapsulated mRNA vaccine for COVID-19 and other diseases.
New clues to why some people suppress HIV without drugs
May 22, 2023 - by Alan Mozes - Some HIV patients are naturally able to keep the virus fully in check without any medicinal help, a phenomenon that has intrigued scientists for decades.
New research appears to identify at least one reason why: an abnormally powerful version of an infection-fighting white blood cell called CD8+ T cell.
Read more...
Grant Funds Study of Cannabis Effects on HIV-Infected Brain Tissue
May 22, 2023 - Weill Cornell Medicine has been awarded a five-year, $11.6 million grant from the National Institute on Drug Abuse (NIDA) of the National Institutes of Health to study the effects cannabis, including marijuana and compounds derived from it, may have on the brains of those living with HIV.
Study Finds Strong Interest in Injectable PrEP for Understudied Malaysian Population
May 22, 2023 - Anna Zarra Aldrich - This novel study explored an understudied group and assessed their interest in a new injectable form of pre-exposure prophylaxis
Researchers in the College of Agriculture, Health and Natural Resources recently conducted a novel study assessing knowledge of and interest in a new injectable form of PrEP (pre-exposure prophylaxis) among men who have sex with men (MSM) in Malaysia.
Thank You, Bob Starkey (1949-2023)
May 22, 2023 - By Shawn Decker - On Saturday, May 20, the HIV/AIDS Community lost a fierce ally, advocate, activist and friend. His work and heart will live on forever.
The HIV/AIDS community lost a precious ally last Saturday.
I learned about Bob’s work, life and passing via The AIDS Memorial on Instagram. He spent his life fighting the good fight wherever it took him... which was, literally, around the world.
Read more...
Watch: AIDS Walk New York 2023 opening ceremonies and interviews from Central Park
New York - MAY 21, 2023 - BY CHRISTINA FAN - Ten thousand New Yorkers took a trek through Central Park on Sunday morning, participating in the largest single-day AIDS fundraising event in the world.
Watch & Read more...
In Their Own Words: An Early Epidemic History
May 20, 2023 - By Sean Strub - Join us for a conversation with Richard Berkowitz, Helen Scheitinger and me about the earliest days of the AIDS epidemic and the creation of the Denver Principles.
I am looking forward to speaking with Richard Berkowitz and Helen Schietinger on Thursday, June 1, at 3 pm EST about the earliest days of the HIV/AIDS epidemic. They are two amazing activists and amongst the dwindling few who can speak first-hand to what happened in those critical first years. Join us to learn about those early days. “in their own words”.
Read more...
Switching From HIV Activism to Personal Cancer Care: An Interview With Stewart Landers
May 19, 2023 - Tim Murphy - It’s well established that people living with HIV (PLWH) face higher likelihoods of developing skin cancers—as well as other kinds of cancers—than the general population, especially as we age. This is true even when we are virally suppressed, which is why it’s so important for PLWH to wear sunblock whenever they’re outside (especially if one is very fair-skinned), get their skin checked head-to-toe by a dermatologist regularly, and also get checked by a provider any time an unusual skin blemish or lesion appears and does not disappear after a few days.
Read more...
Novel Gene-Editing Strategy Leverages Unusual Genetic Alteration to Block HIV Spread in Cells
May 19, 2023 - Genetic alterations that give rise to a rare, fatal disorder known as MOGS-CDG paradoxically also protect cells against infection by viruses. Now, scientists at the Lewis Katz School of Medicine at Temple University have harnessed this unusual protective ability in a novel gene-editing strategy aimed at eliminating HIV-1 infection with no adverse effects on cell mortality.
MPOX VACCINATIONS URGED BY CDC AS NEW CASES INCREASE
May 19, 2023 - by Rick Guasco - Getting vaccinated in time for Pride and summer activities
Concerned about a possible increase in mpox (previously called monkey pox) cases, particularly among men who have sex with men, the Centers for Disease Control and Prevention (CDC) is encouraging vulnerable populations to get fully vaccinated as part of their preparations for Pride and other summer activities.
25 must-read books that humanize the HIV/AIDS experience
May 18, 2023 - Taneasha White-Gibson - Much of the published dialogue and media representation surrounding the epidemic primarily center the harrowing mortality statistics or the subsequent scientific advancement. While these are irrefutable parts of the crisis, it often leaves out the human aspect, erasing the very real impact on relationships, families, and communities.
Read more...
GMHC programs focus on helping long-term HIV/AIDS survivors
May 18, 2023 - GMHC dedicates resources to ending the AIDS epidemic and elevating the lives of those living with HIV/AIDS, and one group in particular needs more help now than ever -- long-term survivors. CBS2's Vanessa Murdock sat down with two long-term survivors who share their stories in hopes of helping others.
GMHC says long-term HIV/AIDS survivors need help now more than ever
MAY 18, 2023 - BY VANESSA MURDOCK - GMHC dedicates resources to ending the AIDS epidemic and elevating the lives of those living with HIV/AIDS, and one group in particular needs more help now than ever -- long-term survivors.
CBS2's Vanessa Murdock sat down with two long-term survivors who share their stories in hopes of helping others.
Watch & Read more...
Injectable HIV-prevention drug to be made in South Africa for the first time
May 18, 2023 - Indian drug company to make cheaper generic version of CAB-LA, potentially protecting millions of people in Africa from the virus
An affordable version of a groundbreaking HIV-prevention drug will be made in South Africa for the first time, potentially giving millions of people at risk of HIV infection in Africa access to a two-monthly jab that can almost eliminate their chances of contracting the virus.
Read more...
Chicago non-profit backs House bill aiming to fund housing for homeless with chronic illness
May 17, 2023 - by: Brónagh Tumulty, Eli Ong - Johnny Pitts has been receiving help from the AIDS Foundation of Chicago (AFC) for about five years, saying the organization is what helped get him back on his feet.
Read more...
BCCDC teams up with Vancouver street artists to promote hepatitis C treatment
MAY 17, -2023 - A mural on the Downtown Eastside warns about the damage hep C can do to people's organs and encourages them to seek more information and treatment.
A new mural in Vancouver’s Downtown Eastside is raising awareness about easily accessible treatments for hepatitis C.
Sofia Bartlett, senior scientist for Sexually Transmitted Infections & Blood-Borne Infections (STIBBI) at the BC Centre for Disease Control (BCCDC), teamed up with Vancouver graffiti artists Smokey Devil and Trey Helten to find a creative way to let people know the curative treatments are free, come in pills, and have no side effects.
40 years after the discovery of HIV
17-MAY-2023 - From virus identification to hopes of a cure, what are the new challenges for research?
Research on the HIV/AIDS epidemic – which continues to be a major public health issue, with 1.5 million new infections worldwide in 2020 (1) – is now a 40-year-long tradition at the Institut Pasteur. The story began when the HIV retrovirus was identified in 1983, and continued with the award of the 2008 Nobel Prize in Physiology or Medicine to Françoise Barré-Sinoussi and Luc Montagnier for this discovery. Another milestone was the sequencing of HIV-1 in 1985, then HIV-2 a few years later, which would pave the way for different therapeutic approaches. The sequencing of reverse transcriptase, a crucial enzyme for viral replication, led to the first antiretroviral drug, AZT, in 1987.
Kyrgyzstan’s MPs put vital HIV funding at risk over ‘national traditions’
May 16, 2023 - Kamila Eshalieva - People living with HIV/AIDS said missing out on the $29m Global Fund grant would have “catastrophic consequences”
“Within a year, the entire system for diagnosing HIV and tuberculosis will begin to collapse,” Aibar Sultangaziyev, deputy chair of the HIV/AIDS coordinating committee board, told openDemocracy.
“The entire laboratory network, updating the infrastructure of laboratories, purchasing substances used to carry out laboratory tests and much more – all this is carried out with money from the Global Fund.”
HIV Survivors Look Back, and Explore the Meaning of ‘Getting to Zero’
May 16, 2023 - By Mark S. King - There are so many governmental and community programs that refer to “ending the HIV epidemic” that you might be excused for rolling your eyes a little when you hear about one. What do they even mean? Ending the HIV epidemic how, you might wonder. And for whom?
Those questions are explored in very personal terms in a new documentary, HIV and the Journey Toward Zero. The documentary is produced by Tessa Films and, surprisingly, by the Chicago Department of Health, with a free virtual screening sponsored by The Reunion Project to be held on Thursday, June 8, at 6:00pm ET
‘No one believed that it would ever come to this place’: Fear and hatred clouded efforts to care for Iowa’s early AIDS patients
May 16, 2023 - by Adria Carpenter - This is the second article in a three-part series examining the legacy of HIV/AIDS in Iowa City.
It’s October 1980, and Jack Stapleton is treating a 19-year-old girl diagnosed with a rare lung infection: pneumocystis carinii pneumonia.
Read more...
Gay men can now donate blood after FDA changes decades-old rule – a health policy researcher explains the benefits
May 16, 2023 - The U.S. Food and Drug Administration announced on May 11, 2023, that it has officially dropped restrictions that prohibit gay and bisexual men from donating blood under many circumstances on May 11, 2023. The ban was initially put in place in the early days of the AIDS epidemic, but for years medical professionals and gay rights advocates have argued that the ban was no longer medically justifiable and that it unnecessarily discriminated against men who have sex with men.
Neglected 80-year-old antibiotic is effective against multi-drug resistant bacteria
May 16, 2023 - An old antibiotic may provide much-needed protection against multi-drug resistant bacterial infections, according to a new study publishing May 16th in the open access journal PLOS Biology by James Kirby of Harvard Medical School, US, and colleagues. The finding may offer a new way to fight difficult-to-treat and potentially lethal infections
BC-CfE Webinar:
Aging Well While Living With HIV
BC-CfE Webinar Learning Series Event
Audience: General Public
Wednesday, May 17, 2023, 12:00 pm - 1:00 pm
This webinar will be presented by:
Silvia Guillemi, MD, Marianne Harris, MD and Viviane Lima, MSc PhD
Presentations will be followed by a discussion where participants will have the opportunity to ask questions and receive real-time responses from presenters.
Center for Infectious Disease Dynamics hosts infectious disease conference
UNIVERSITY PARK, Pa. - May 15, 2023 - Members of the University community who have not registered can attend individual talks during the Ecology and Evolution of Infectious Disease conference, May 22-25.
The Penn State Center for Infectious Disease Dynamics (CIDD) will welcome 350 scientists from around the globe to discuss parasites and pathogens affecting plants, animals and humans, as part of the Ecology and Evolution of Infectious Disease conference. Twenty years after the inaugural meeting at the University, the meeting will be held from May 22 to 25, on the Penn State University Park campus.
Potential Risk for New Mpox Cases
May 15, 2023 - Distributed via the CDC Health Alert Network
In the United States, cases of mpox (formerly monkeypox) have declined since peaking in August 2022, but the outbreak is not over. The Centers for Disease Control and Prevention (CDC) continues to receive reports of cases that reflect ongoing community transmission in the United States and internationally.
BC-CfE Celebrates 30 Years of Excellence
Chapter 5 | Building from Treatment as Prevention® - Where does HIV research and care go from here?
Wednesday, May 31, 2023, 12:00 pm - 1:00 pm
Speaker: Kate Salters, PhD, MPH
Learning Series Event
UNAIDS urges all countries to decriminalise homosexuality as a vital step in ensuring health for all
GENEVA, 15 May 2023 - Released ahead of the International Day against Homophobia, Transphobia and Biphobia – 17 May 2023
Around the world, 67 countries still criminalise same sex relations, with 10 imposing the death penalty. 20 countries criminalise gender diversity. Such laws hurt the public health of everyone, costing lives. Public health and human rights go hand in hand.
“The importance of decriminalising homosexuality and gender diversity cannot be underestimated,” said Christine Stegling, Deputy Executive Director, Policy, Advocacy and Knowledge, UNAIDS. “Decriminalising will save lives and is a crucial step towards equality, dignity, and health for all.”
'Lucky to still be alive': Living with HIV for over 30 years
Paris - May 14, 2023 - By Daniel Lawler and Isabelle Tourne - When people were diagnosed with HIV more than three decades ago, it was considered a death sentence.
But after suffering through discrimination, the loss of loved ones and brutal side effects from drugs, advances in treatment over the years have allowed millions to live with the virus.
To mark the 40th anniversary of the discovery of the virus that causes AIDS, AFP spoke to four long-term survivors about their experience.
Read more...
HPV Self-Collection Kits Increase Screening Among Under-screened, Under-served Women in North Carolina
CHAPEL HILL, NC - May 12, 2023 - Jennifer S. Smith, PhD, in UNC Gillings School of Global Public Health, UNC’s School of Medicine, and Lineberger Comprehensive Cancer Center, led the Phase 3 controlled trial, which showed that self-collection kits and scheduling assistance are key for reaching these populations and preventing cervical cancer.
Five years ago, the World Health Organization (WHO) announced a global call to eliminate cervical cancer. Because nearly all cervical cancers are caused by an initial infection with oncogenic types of human papillomavirus (HPV), screening for the virus is critical to preventing and treating the disease.
New study highlights the evidence gap on the quality of antiretrovirals globally
12 May 2023 - A new study suggests that, although there is sparse evidence,substandard and falsified (SF*) antiretrovirals occur and enhanced surveillance is needed.
The paper, The quality of antiretroviral medicines: an uncertain problem, was published in BMJ Global Health.
From the very limited available data, the Medicine Quality Research Group of the MORU Tropical Health Network, NDM-CGHRand IDDO found that 1.4 per cent of antiretrovirals reported as sampled in the scientific literature were substandard or falsified.
The Lancet Public Health: Mailing at-home HPV sampling kits nearly doubles cervical screening uptake among hard-to-reach populations, US clinical trial suggests
May 12, 2023 - At-home high-risk human papillomavirus (hrHPV) sampling kits can help increase cervical cancer screening among under-screened women from low-income backgrounds, according to findings from a US-based clinical trial published in The Lancet Public Health journal.
Join More than 20 Global Health and Safety Organizations Pledging Support to Mitigate Spread of COVID-19 and Other Infectious Diseasesmpox
May 11, 2023 - FALLS CHURCH, Va.--(BUSINESS WIRE)-- Commit To C.A.R.E. Initiative Urges Employers to Join Efforts to Ensure Safe Communities, Workplaces
Six professional health and safety associations have joined a growing number of employers formally pledging their support to a new nationwide program aimed to keep employees and communities safe from the ongoing threat of COVID-19, flu, and other infectious diseases. Since its launch in 2022, Commit To C.A.R.E. has attracted numerous businesses – as well as public health and occupational health and safety organizations – and provided them with free tools and resources to address these continued public health threats.
GMHC Statement in Response to Potential Changes to the FDA Blood Ban
May 11, 2023 - GMHC, founded in 1982 as the world’s first HIV and AIDS services organization, is responding to news first reported in the Wall Street Journal that the FDA will implement a new individual risk assessment that could allow gay, bisexual, and other men who have sex with men (MSM) to donate blood if they have not had anal sex with a new partner in the previous three months. This includes MSM in monogamous relationships or who have been celibate. Currently, the FDA requires all MSM to be celibate for three months in order to donate blood and plasma.
More people with HIV in England have dropped out of care than remain undiagnosed
11 May 2023 - Gus Cairns - As many as 20,000 of the approximately 96,000 people in England who are living with HIV may not be virally suppressed, so could potentially be able to infect others, the British HIV Conference heard in Gateshead last month.
Read more...
More gay and bisexual men can donate blood under new FDA rules
May 11, 2023 - By Berkeley Lovelace Jr. - The Food and Drug Administration said Thursday that it finalized a new rule that will allow more gay and bisexual men to donate blood.
Read more...
FDA Finalizes Move to Recommend Individual Risk Assessment to Determine Eligibility for Blood Donations
May 11, 2023 - Today, the U.S. Food and Drug Administration finalized recommendations for assessing blood donor eligibility using a set of individual risk-based questions to reduce the risk of transfusion-transmitted HIV. These questions will be the same for every donor, regardless of sexual orientation, sex or gender. Blood establishments may now implement these recommendations by revising their donor history questionnaires and procedures.
Viral Hepatitis Deaths Projected to Exceed HIV, TB, and Malaria Combined by 2040
GENEVA - MAY 10, 2023 - by Lisa Schlein - Health agencies warn that viral hepatitis could kill more people by 2040 than HIV, tuberculosis and malaria combined if it remains a neglected disease and efforts to fight it remain underfunded.
Read more...
No longer a death sentence: Four decades of living with HIV
MAY 10, 2023 - by Olivier THIBAULT - Forty years after the discovery of HIV, AFP looks at how far we have come in fighting a deadly virus that was once shrouded in fear and shame but is now treated as a manageable chronic condition.
Read more...
Rutgers Experts Aim to Uncover Barriers to Conducting HIV Research in Africa
May 10, 2023 - Researchers are involved in a study on youth populations that is backed by a $3 million grant from the National Institutes of Health
Rutgers has received a $3 million grant from the National Institutes of Health to conduct a four-year study to explore the legal and ethical barriers to conducting HIV research with youth populations in central, east, west and southern Africa.
The goal of researchers from the Rutgers Institute for Health, Health Care Policy and Aging Research (IFH) is to identify challenges to conducting research and develop strategies for overcoming these barriers to HIV research.
One step closer to eliminating latency, the real challenge in combating HIV
10-May-2023 - by Universitat Pompeu Fabra- Barcelona - An international study coordinated by the MELIS-UPF researchers Andreas Meyerhans and Juana Díez has identified Schlafen 12, a new HIV restriction factor that could pave the way for new strategies for curing the infection.
Newswise — A worldwide research conducted by MELIS-UPF scientists from the Infection Biology and Molecular Virology departments has detected and defined Schlafen 12 (SLFN 12) as a new HIV limiting element. SLFN 12 terminates the generation of viral proteins and aids cells infected with the virus to evade anti-HIV therapy and immune reactions. These discoveries open the path for enhancing therapeutic methods that strive to heal HIV infections.
Is Mpox Making a Comeback?
May 10, 2023 - By Liz Highleyman - Recent case clusters in Chicago and France include several people who were fully vaccinated.
Health officials in Chicago have reported a new cluster of 13 mpox (formerly monkeypox) cases, following a small outbreak in France in March. Although the number of cases remains low, the new clusters raise concern about the possibility of a resurgence this summer.
Read more...
Tuberculosis Disease Intensifies HIV Antibody Response in People with HIV
Boston - May 9, 2023 - New research from Boston Medical Center found that people living with HIV that have had pulmonary tuberculosis had broader and more potent HIV antibody responses and differences in HIV sequences predicted to be antibody resistant as compared to those without suspected or documented tuberculosis. Published in iScience, the study suggests that concomitant tuberculosis disease has a significant impact on HIV immune responses and the viruses circulating in people living with HIV.
U.S. Loses Key Case on Rights to H.I.V.-Prevention Drugs
May 9, 2023 - By Rebecca Robbins - A jury sided with Gilead Sciences in a dispute over whether the government could claim a share of profits from drugs seen as crucial to ending the H.I.V. epidemic.
A federal jury in Delaware on Tuesday found that the federal government did not have an ownership claim to lucrative drugs to prevent H.I.V. that are sold by the pharmaceutical company Gilead Sciences.
Read more...
HIV controllers may be more susceptible to non-AIDS-defining events compared to people on HIV treatment
9 May 2023 - Andy Carstens - A new study finds that HIV controllers – people who don’t need HIV treatment to maintain viral loads below 400 copies – are twice as likely to experience certain non-AIDS-related health conditions, particularly infections such as bronchitis. The results raise the questions of whether antiretroviral therapy (ART) might benefit some controllers and under what conditions.
Read more...
During the ‘wild, bucking ’70s’, Iowa City’s lesbian and gay communities were often at odds. A crisis brought them together.
May 8, 2023 - by Adria Carpenter - This article is part one in a three-part series from Adria Carpenter exploring the history of HIV/AIDS activism in Iowa City. Part two and three will be published in the weeks to come.
In the early 1980s, Rev. John Harper was a fresh-faced graduate student at the University of Iowa and a semi-active member of the Gay People’s Union.
He’d heard about some disease affecting gay men in New York and San Francisco. He started being more careful, though he doubted whatever it was would spread as far as Iowa.
Read more...
The Reunion Project: Long-term Survivors in the Rural South
WEDNESDAY MAY 10, 2023
Register now
Join The Reunion Project on Wednesday, May 10 from 6-7:15pm ET for the next webinar in the Long-term Survivors Toolkit Series, "Long-term Survivors in the Rural South." During this webinar, we will hear the true lived experiences of individuals living with HIV long-term in the rural South. We will explore their challenges and discuss potential solutions by hearing from two panelists, a keynote speaker, and a robust Q&A session to conclude the webinar. We look forward to seeing you there!
Penn State research team receives NIH grant to study HIV treatment messaging
UNIVERSITY PARK, Pa. - MAY 8, 2023 - By Jonathan F. McVerry - An interdisciplinary team of Penn State researchers have received a $442,750 grant from the National Institute of Mental Health to support a multi-faceted, three-part study that observes how gay and bisexual men search and find HIV prevention information — specifically information about pre-exposure prophylaxis (PrEP), a medicine that when taken as prescribed, is very effective at preventing HIV.
New Subtype of KS Emerges Among MSM Without HIV
MAY 8, 2023 - By Myles Starr - A new subtype of Kaposi sarcoma (KS) has been described among men who have sex with men (MSM) who do not have HIV
Bloomberg Nursing Week 2023 – Keynote Lecture
Breaking Barriers: The Future of Nursing and the Fight for Global Health Equity
May 9 @ 4:00 pm - 6:00 pm Free
with Professor Sheila Tlou
Bloomberg Nursing is pleased to welcome Professor Sheila Tlou as our honoured guest speaker for National Nursing Week. Sheila’s talk will weave together stories of her own advocacy and health policy work in the areas of HIV prevention in Southern Africa, alongside her visionary leadership as co-chair of the International Council of Nurses Nursing Now campaign and Global HIV Prevention Coalition, to illustrate the broad impact that nurses can have in the fight for global health equity.
We HIV medical specialists want to clear the record on antiretroviral treatment | Opinion
May 6, 2023 - Ten HIV doctors and researchers Guest Columnists - Ill-informed opinions will not end the HIV epidemic. Evidence-based HIV treatments will. Perpetuating dangerous misinformation will only serve to set us back.
We write as infectious diseases specialists who live and work as HIV physicians and researchers in Tennessee to correct the record regarding numerous falsehoods in the guest opinion column on April 25 entitled: “Why Tennessee's decision to reject federal AIDS funding was the right move”.
Read more...
HIV Patients Fare Well with Mpox Treatment
May 5, 2023 - Patients with HIV had similar treatment outcomes to patients without HIV when treated for mpox with an antiviral drug called tecovirimat, according to a study by a team of investigators from Weill Cornell Medicine, Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian.
The results of the study, published May 2 in the Annals of Internal Medicine, provide preliminary evidence of the safety and efficacy of the drug in those living with HIV.
A bill to restrict HIV/AIDS and HPV education in Iowa schools harkens back to the darkest days of the Reagan era
May 5, 2023 - by Paul Brennan - Thirty-six years after the Reagan administration began a long-delayed public education campaign about HIV/AIDS, Gov. Kim Reynolds and Republicans in the Iowa Legislature have decided that education about HIV/AIDS is no longer needed in public schools.
One of the provisions of SF 496 — a bill introduced by the governor’s office that makes major changes to Iowa’s schools — eliminates the requirement that a public school provide students with age-appropriate information about HIV/AIDS as part of its health curriculum..
Hong Kong researchers suggest HCMV detection in urine as routine test for HIV-1 patients
05 May 2023 - Easier to detect HCMV in urine than in blood
A Hong Kong Baptist University (HKBU) collaborative research team has shown that urine tests for human cytomegalovirus (HCMV) can identify the risk of end-organ diseases such as pneumonitis, gastrointestinal ulcers, hepatitis and myocarditis, earlier in patients who have been infected with human immunodeficiency virus type 1 (HIV-1).
Statement on the fifteenth meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic
5 May 2023 - The WHO Director-General concurs with the advice offered by the Committee regarding the ongoing COVID-19 pandemic. He determines that COVID-19 is now an established and ongoing health issue which no longer constitutes a public health emergency of international concern (PHEIC).
Uganda’s anti-homosexuality bill threatens HIV progress
5-May-2023 - by SciDev.Net - Uganda’s anti-homosexuality bill, if signed into law, could lead to the withdrawal of foreign aid and threaten goals to end HIV/AIDS by 2030, advocates warn.
Uganda’s parliament passed the revised Anti-Homosexuality Act (AHA), which criminalises homosexual conduct, with minimal amendments this week (2 May).
UNAIDS calls for access to HIV prevention, treatment and care in prisons, including access to life saving harm reduction services
GENEVA, 5 May 2023 - Harm reduction policies and practices help people who are using drugs to stay alive and protect them from HIV and Hepatitis C
Released ahead of International Harm Reduction Day - 7 May 2023
Many prison systems are struggling to cope, with overcrowding, inadequate resources, limited access to healthcare and other support services, violence and drug use. In 2021, the estimated numbers of people in prisons increased by 24% since the previous year to an estimated 10.8 million people, increasing the strain on already overstretched prison systems.
Theratechnologies’ Trogarzo® (Ibalizumab-uiyk) Shortens Time to HIV Undetectability and Extends Durability of Undetectability and Viral Suppression in a Matched Treatment Comparison
MONTREAL, May 04, 2023 (GLOBE NEWSWIRE) -- First-of-its-Kind Study in HIV Compares Ibalizumab Clinical Trial Experience to Matched Real-World Non-Ibalizumab OPERA® Cohort
Data Presented at ACTHIV™ Conference Highlight Improved Clinical Outcomes of Ibalizumab for Heavily Treatment-Experienced People with HIV
Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today presented data from a landmark study in which the use of ibalizumab, a monoclonal antibody antiretroviral therapy (ART) commercialized as Trogarzo®, was associated with favorable virologic outcomes compared to non-ibalizumab regimens used in routine care in heavily treatment-experienced people with HIV.
Community Forum:
The Long-Acting Treatment Era Begins
Tuesday, May 16th 2023
5:30 PM – 8:00 PM
1167 Davie Street, Vancouver, British Columbia
Join us for an enlightening evening, where we'll dive into the latest advancements in long-acting treatments.
Demonstrators demand action on safe-injection sites to stem rising HIV, AIDS rates in Manitoba
May 4, 2023 - By: Malak Abas - Community organizations delivered a stark message to the province on the steps of the Legislative Building Thursday afternoon: do more to fight HIV and AIDS, or suffer the consequences of a health care-crisis.
Recent rising HIV infection case counts have been troubling for front-line service providers who say Manitoba’s history of colonialism and unjust treatment of those who inject drugs have resulted in some of the highest patient counts in the country.
Read more...
Black Women Researchers Are Needed to Make PrEP Use More Equitable: Interview With Danielle Campbell, M.P.H.
May 4, 2023 - Michael Chancley Jr., M.S.W. - While concluding her presentation, “Taking control over our bodies: Black women, sex, violence, and HIV,” at NMAC’s Biomedical HIV Prevention Summit in Las Vegas this past April, HIV prevention researcher and advocate Danielle Campbell, M.P.H., suddenly shared the words of freedom fighter Assata Shakur:
Read more...
MSF calls on Gilead to finally fulfil access promise and make lifesaving drug for people with HIV available where needed
Geneva, 3 May 2023 - Gilead hikes price while liposomal amphotericin B (L-AmB) for treatment of HIV-related cryptococcal meningitis remains unavailable and unaffordable in countries where it’s most needed
Ahead of Gilead Sciences’ annual meeting of stockholders today, Médecins Sans Frontières/Doctors Without Borders (MSF) called on the US pharmaceutical corporation to finally fulfil its 2018 promise and ensure that the lifesaving drug L-AmB (marketed as Ambisome) for the treatment of cryptococcal meningitis in people with HIV is immediately available to all the 116 low- and middle-income countries (LMICs) eligible for Gilead’s ‘access price.’ MSF made this call in the wake of Gilead’s announcement that it will increase the ‘no-profit’ access price of L-AmB by 40% from US$16.25 to $23 per vial in 2024, a move that may further impede people’s already limited access to this drug in LMICs. Under the recommended treatment protocol, approximately 12 vials of L-AmB are required to treat cryptococcal meningitis, around $267 per person at Gilead’s new ‘no-profit’ access price.
NIH researchers uncover new details on rare immune disease
May 3, 2023 - Idiopathic CD4 lymphocytopenia leaves immune system vulnerable to other diseases, cancers.
In an 11-year study, researchers at the National Institutes of Health have further characterized idiopathic CD4 lymphocytopenia (ICL), a rare immune deficiency that leaves people vulnerable to infectious diseases, autoimmune diseases and cancers. Researchers observed that people with the most severe cases of ICL had the highest risk of acquiring or developing several of the diseases associated with this immune deficiency. This study, published in the New England Journal of Medicine, was led by Irini Sereti M.D., M.H.S. and Andrea Lisco, M.D., Ph.D. of the HIV Pathogenesis Section in the Laboratory of Immunoregulation at the National Institute of Allergy and Infectious diseases (NIAID), part of NIH, and conducted at the NIH Clinical Center.
AHF and PAHO Make Partnership Official
May 3, 2023 – by Denys Nazarov - AIDS Healthcare Foundation (AHF) and the Pan American Health Organization (PAHO) met in Washington D.C. earlier this week, where the organizations entered into an official partnership to fight HIV/AIDS, other sexually transmitted infections, and other conditions, including tuberculosis, hepatitis viruses, and mpox.
Multi-functional Downtown Eastside support clinic opens its doors
May 3, 2023 - By John Ackermann and James Paracy - A new clinic opened on the Downtown Eastside Wednesday, aimed at addressing the many complex health and social challenges affecting the community.
The Vancouver Urban Health Centre is headed by medical director Dr. Brian Conway. He says the facility can give people “an opportunity to engage themselves in the care that they need.”
Read more...
Study shows HIV status does not change treatment outcome for mpox
May 2, 2023 - Stephanie Soucheray, MA - HIV status did not affect treatment outcomes in mpox patients treated with the antiviral tecovirimat (Tpoxx), according to findings published today in the Annals of Internal Medicine.
The study, conducted by researchers from Columbia University Medical Center and NewYork Presbyterian Hospital, included 196 people treated with tecovirimat in New York City from June 20 to August 29, 2022, during the height of the mpox outbreak in the United States. Of 154 patients who tested positive for mpox, 72 were also HIV-positive, 82 were HIV-negative, 134 completed at least 1 follow-up visit, and 88 completed a posttreatment follow-up.
HIV Research Failures Prompt Announcement of $50K PETA Grant
Atlanta – May 2, 2023 - PETA is pleased to announce that it will bankroll a $50,000 grant to fund a first-of-its-kind study to explore the exact reasons why attempts to develop a vaccine against HIV have failed to produce a viable one for humans.
No vaccine for HIV exists, despite billions in taxpayer funding and decades of research. In an effort to break this stagnation, PETA is offering this generous funding for a researcher to conduct a systemic review of studies in which monkeys were used to test HIV vaccines and compare that data to the testing of those same vaccines in humans.
VIDEO-BASED SMOKING CESSATION PROGRAM HELPED HIV-POSITIVE SMOKERS QUIT TOBACCO
May 2, 2023 - UMass Amherst researcher now developing smartphone app to expand the pilot program in low- and middle-income countries
Nearly 40% of participants in a pilot study quit tobacco after completing a video-based smoking cessation intervention developed by a University of Massachusetts Amherst community health researcher for HIV-positive smokers in Nepal.
“I am blown away with the findings,” published in the journal AIDS and Behavior, says lead author Krishna Poudel, associate professor of community health education in the School of Public Health and Health Sciences. “I was confident that a lot of people would quit, but I was not expecting 40%.”
Chances of eliminating HIV infection increased by novel dual gene-editing approach
May 1, 2023 - Gene-editing therapy aimed at two targets – HIV-1, the virus that causes AIDS, and CCR5, the co-receptor that helps the virus get into cells – can effectively eliminate HIV infection, new research from the Lewis Katz School of Medicine at Temple University and the University of Nebraska Medical Center (UNMC) shows. The study, published online in the journal The Proceedings of the National Academy of Sciences (PNAS), is the first to combine a dual gene-editing strategy with antiretroviral drugs to cure animals of HIV-1.
Mother-to-baby HIV transmission shouldn't be happening in Canada, researchers say
May 1, 2023 - Nicole Ireland - A new study concludes a few pregnant women in Canada are passing HIV to their babies, despite the fact that this country has all the tools needed to stop it from happening.
Researchers combed through an HIV surveillance database and found 33 babies born in Canada between 2012 and 2021 were infected during pregnancy or delivery.
Read more...
Sydney AIDS Candlelight Memorial – An International Day of Remembrance
MAY 1, 2023 - By RONTE NICHOLLS - Each year, friends and family members who have lost people to AIDS come together to commemorate their loved ones at the Sydney AIDS Candlelight Memorial at Eternity Playhouse in Darlinghurst.
This year it will be held on May 21 in coordination with the Global Network of People Living with HIV (GNP+). The GNP+ organise an International effort in honour of those lost with candlelight vigils on the 3rd Sunday of May. Their intention for these memorials is to create an “important platform for global solidarity, breaking down barriers of stigma and discrimination, and giving hope to new generations.” They have been held across the globe every year since 1983.
Read more...
|
